KWESST Micro Systems Announces Q1 2024 Financial Results and Provides Corporate Update
- Focused investments in defense contracts and non-lethal munition systems drive KWESST's strategy.
- Adjusted EBITDA loss increased in Q1 2024 due to decreased revenue and higher operating expenses.
- KWESST reports a negative gross profit in Q1 2024 compared to a profit in the same period in 2023.
- The company anticipates increased revenue from Canadian Government contracts and new product lines in the future.
- Key highlights include product introductions, patent approvals, and strategic appointments.
- Operating expenses increased in Q1 2024 due to various factors such as G&A, S&M, and R&D expenses.
- KWESST aims to win large defense contracts for revenue visibility while focusing on public safety market sales.
- The company reported a net loss of $0.4 million in Q1 2024 with total revenue decreasing by $0.2 million.
- KWESST's strategy involves cost reductions through the elimination of consultant fees and focused R&D spending.
- The company plans to scale up production of PARA OPS and ARWEN products for law enforcement agencies.
- KWESST appoints new key executives and advisors to drive strategic growth and expansion.
- The company expects revenue growth as it continues to hire and deploy resources under government contracts.
- Total revenue and gross profit decreased in Q1 2024 compared to the prior year period.
- Operating loss increased by 65% in Q1 2024 due to various factors including increased G&A expenses.
- Adjusted EBITDA loss increased by $0.8 million in Q1 2024 mainly due to decreased revenue and higher operating expenses.
- The gross profit was negative $0.1 million in Q1 2024 compared to a profit of $0.2 million in the same period in 2023.
- Total operating expenses increased by $0.8 million in Q1 2024 compared to Q1 2023.
- KWESST's net loss was $0.4 million in Q1 2024 with total revenue decreasing by $0.2 million.
- The company incurred selected impairment charges and increased compliance-related costs following its listing on Nasdaq.
- KWESST's strategy involves reaching commercial feasibility for products resulting in expensing all related costs.
- The company anticipates revenue growth from Canadian Government contracts and order backlog for new products.
- KWESST expects gross profit / margin to be positive and increase during Fiscal 2024 as it ramps up revenue.
- Total OPEX increased in Q1 2024 due to factors such as G&A, S&M, and R&D expenses.
- KWESST aims to exploit book-and-ship business in the public safety market to drive sales growth.
- The company plans to ramp up production of PARA OPS products and new ARWEN 40mm ammunition.
- KWESST's total other income was $2.1 million in Q1 2024 compared to total other expenses of $0.7 million in Q1 2023.
- The change in other income (expenses), net was mainly driven by the change in fair value of warrant liabilities.
- KWESST's revenue decreased in Q1 2024 mainly due to a reduction in the sale of ARWEN products.
- The company expects revenue to increase as it hires and deploys resources under government contracts.
- KWESST's strategy involves pursuing large defense contracts for programmatic revenue visibility.
- Operating expenses increased in Q1 2024 due to various factors such as G&A, S&M, and R&D expenses.
- The company expects revenue growth as it continues to hire and deploy resources under government contracts.
Insights
The reported financial results of KWESST Micro Systems Inc. for Q1 Fiscal 2024 indicate a contraction in revenue and gross profit, alongside an increased operating loss. This is primarily attributed to the restructuring of the Arwen product line and the expensing of costs associated with the Para OPS products reaching commercial feasibility. The company's strategic pivot towards securing large defense contracts and commercializing its Non-Lethal Munition Systems is evident, yet this transition phase has incurred increased general and administrative (G&A) expenses and research and development (R&D) costs.
From a financial perspective, the increase in net loss and adjusted EBITDA loss is concerning, particularly for investors seeking stability and growth. However, the management's emphasis on programmatic revenue visibility and the potential for shorter sales cycles in the public safety market could pave the way for future revenue growth. The cost reduction measures, such as the elimination of consultant fees, indicate an attempt to streamline operations and improve financial health.
Additionally, the company's listing on the Nasdaq has introduced compliance-related costs, which are common for companies expanding their market presence. The mixed financial results underscore the importance of closely monitoring KWESST's ability to convert its strategic initiatives into tangible financial improvements in subsequent quarters.
Examining KWESST Micro Systems Inc.'s market position, the defense sector is known for long procurement cycles and high barriers to entry. The company's focus on securing large defense contracts and expanding its product offerings, such as the new ARWEN 40mm munition and PARA OPS non-lethal system, is a strategic move to diversify and solidify its market share. However, the reported decrease in sales of existing products raises concerns about the company's current market penetration and the effectiveness of its restructuring efforts.
The appointment of key personnel such as Sean Homuth as President and CEO and the engagement of Dave Ibbetson as a Strategic Defense Advisor, could strengthen the company's leadership and strategic direction. The anticipation of a subcontract with a global defense contractor for digitization services also highlights KWESST's potential to secure new revenue streams.
Despite the short-term financial setbacks, the company's attendance at industry events like the SHOT Show and the introduction of new products could stimulate interest and demand. The market will be observing whether these initiatives can translate into increased sales and market presence, particularly in the highly competitive defense and public safety sectors.
From a legal and regulatory standpoint, KWESST's financial results reflect the company's compliance with International Financial Reporting Standards (IFRS) as evidenced by the fair value remeasurement of warrant liabilities. Such transparency in financial reporting is crucial for investor confidence, especially following a listing on a major exchange like the Nasdaq, which comes with stringent reporting requirements.
The announcement of the Luxton Low Energy Cartridge (LEC) patent allowance by the USPTO is another significant legal development for KWESST, potentially strengthening its intellectual property portfolio and offering a competitive edge in the defense technology market. Patents not only provide legal protection for innovations but also can be a critical factor in attracting partnerships and contracts with prime defense contractors.
It is also noteworthy that the company is proactively managing its legal obligations through the issuance of common shares in settlement of debt, which can be an effective strategy to manage cash flow while maintaining compliance with financial agreements. Investors typically view such proactive legal management as a positive governance practice.
Ottawa, Ontario--(Newsfile Corp. - February 15, 2024) - KWESST Micro Systems Inc. (TSXV: KWE) (TSXV: KWE.WT.U) (NASDAQ: KWE) ("KWESST" or the "Company") is pleased to announce the highlights of its fiscal 2024 first quarter results. This announcement is a summary only and should be read in conjunction with KWESST's unaudited condensed consolidated financial statements and related management discussion and analysis, for the three-month period ended December 31, 2023 ("Q1 2024 FS"). Q1 2024 FS have been filed on SEDAR and will be filed on EDGAR in due course.
In Q1 2024, KWESST's total revenue and gross profit decreased by
KWESST Q1 2024, along with its fiscal 2023 performance reflects the Company's strategy of focused investments in key areas: securing large defense contracts, and the commercialization of its line of Non-Lethal Munition Systems including the PARA OPS next generation non-lethal system, and a new ARWEN 40mm munition. Operating expenses for the period increased due to selected impairment charges, corporate headcount growth, and compliance-related costs following the Company's listing on the Nasdaq. The Company has in parallel implemented cost reductions through the elimination of consultant fees and a more focused approach on its R&D spending.
"Our strategy is to pursue and win large defense contracts with prime defense contractors for programmatic revenue visibility several years out, while at the same time exploiting book-and-ship business in the public safety market where it is possible to drive sales and where the sales cycle is typically shorter."
Results of Operations
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7366/198041_table%201-kwesst.jpg
For Q1 Fiscal 2024, KWESST's net loss was
Revenue
Total revenue decreased by
We expect revenue to increase as we continue hiring and deploying resources under the recently announced Canadian Government contract which saw revenue commence in Q1 2024. As the transition from the incumbent continues, we expect to receive, and hire and staff against additional work tasks. We also expect revenue to increase as we work through current order backlog from ARWEN as well as expected demand/future order for the new ARWEN 40mm ammunition and PARA OPS products.
Gross Profit
In Q1 Fiscal 2024, the gross profit was a negative
Operating Expenses ("OPEX")
Total OPEX was
- G&A increased by
$0.4 million , primarily due to the amortization of the LEC intangible in Q1 2024 ($0.3 million ) as well as an increase in senior management and directors compensation to be in line with market and additional personnel as compared to Q1 2023; - S&M increased by less than
$0.1 million , primarily due to an increase in consulting fees in Q1 2024 as compared to Q1 2023; and - R&D increased by
$0.4 million , primarily due to the fact that the LEC has reached commercial feasibility and any associated costs are no longer being capitalized, while it was still in the development stage in Q1 2023.
Other income (expenses), net
For Q1 2024, our total other income was
$0.5 million decrease in net finance costs is primarily due to the Q1 2023 recognition of the remaining unamortized accretion costs and interest expense relating to the repayment of all outstanding loans, following the closing of the U.S. IPO and Canadian Offering;- Q1 2023 had
$1.4 million in Share Offering Costs relating to the U.S. IPO and Canadian Offering. There were no offerings in Q1 2024; and $0.2 million increase in foreign exchange gain due to depreciation in the U.S. currency during the period.
Condensed Balance Sheet
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7366/198041_table%202.jpg
Major Highlights - Quarter ended December 31, 2023 ("Q1 Fiscal 2024")
The following is a summary of the major highlights that occurred during the quarter ended Q1 Fiscal 2024:
On October 18, we announced our "Lightning" scalable situational awareness solution for Public Safety market agencies during a critical incident. KWESST Lightning will improve interoperability between agencies with lightning-fast time to engagement, offered as fully cloud-based Software as a Service ("SaaS") product. Built using the "TAK" - the U.S. government Team Awareness Kit software at the foundation, the solution addresses the issues of scalability, interoperability, and time to engagement while customizing the user experience to meet the demands of the specific mission sets that responders encounter.
On October 31, we announced that we intended to issue 46,706 common shares at a deemed price per share of CAD
$2.09 in settlement of a debt in an amount of approximately CAD$97,615. On October 24, we announced that we received Notice of Allowance for the Luxton Low Energy Cartridge (LEC) patent from USPTO and notification that the USPTO will issue the patent October 31, 2023.
On November 13, we announced plans to expand our ARWEN business, including the introduction of a new 40mm cartridge for third-party riot control launchers, which constitute the bulk of launchers worldwide. In order to scale supply and deliver orders in a more responsive fashion we announced a planned reorganization of the business to satisfy the backlog of ARWEN orders and drive sales growth.
We also reported on the scale-up of PARA OPS production on the heels of successful demonstrations to law enforcement agencies over the summer and fall of 2023.
On November 27, we announced our Board of Directors (the "Board") had appointed Sean Homuth as President and CEO and Kris Denis as interim CFO and Chief Compliance Officer.
On December 6, we announced the appointment of General (Retired) Rick Hillier to the board of directors. General Hillier is the former Chief of Defense Staff of the Canadian Armed Forces.
On December 13, we announced that our non-lethal PARA OPS and ARWEN products will be available for law enforcement agencies to purchase on-line (with link from KWESST website) on Monday, December 18, 2023. PARA OPS has been in initial production through the fall of 2023, and the Company plans to ramp up for volume production in early calendar 2024 in conjunction with the promotion of PARA OPS at the 2024 SHOT Show held in Las Vegas, January 23-26. KWESST also introduced its new ARWEN 40mm cartridge at the SHOT Show in response to substantial interest from many law enforcement agencies.
The following is a summary of major highlights that occurred since Q1 Fiscal 2024:
On February 2, 2024, we announced that Dave Ibbetson, former General Manager of General Dynamics C4 Systems International, and General Dynamics Mission Systems International ("GDMS") has been engaged as a Strategic Defense Advisor.
On February 5, 2024, we announced highlights from the Company's attendance at SHOT Show 2024. This included many law enforcement agencies at the federal, state and local level, plus foreign distributors from Europe, Asia, Latin America and the Middle East, specifically seeking out the Company to view the new products. The Company has started receiving initial small quantity orders for test and evaluation of its 40mm baton ammunition as well as requests from various agencies for live demonstrations of the Para OPS products.
Corporate Updates
The Company announced the appointment of Harry Webster as Chief Operating Officer effective immediately. Mr. Webster joined the Company in August 2023 as General Manager. Mr. Webster is an experienced business leader with over 20 years of experience in aerospace and defense. Harry has held senior leadership positions at General Dynamics, DRS Technologies, and MacDonald Dettwiler and Associates. His leadership has driven successful execution of some of Canada's premiere acquisition programs such as the Canadian Space Agency's Canadarm3 Program and the Canadian Navy's CH-148 Cyclone Maritime Helicopter Program. Additionally, he has a proven track-record of delivery of advanced products into many of the US Army and Marine Corps' ground combat platforms such as M1A1 Main Battle Tank, the Stryker Family of Vehicles, Bradley Fighting Vehicle, Joint Light Tactical Vehicle, and M777 Towed Howitzer. Harry holds advanced degrees in Business Administration and Engineering, and licenses as Professional Engineer and Project Management Professional.
The Company anticipates being under subcontract in the next 90 days with a global defense contractor to provide digitization services for a G7 government military program. If successfully concluded, the Company anticipates that the subcontract would be of similar scale as the previously announced DSEF contract with the Canadian Department of National Defense (see news release dated May 02, 2023). The outcome and amount of this subcontract remains subject to a series of conditions beyond the Company's control.
For further information, please contact:
Kris Denis, Interim Chief Financial Officer and Chief Compliance Officer
+1 (613) 250-9752
denis@kwesst.com
Sean Homuth, President and CEO
homuth@kwesst.com
Jason Frame, Investor Relations
+1 (587) 225-2599
frame@kwesst.com
About KWESST
KWESST (TSXV: KWE) (TSXV: KWE.WT.U) (NASDAQ: KWE) develops and commercializes breakthrough next-generation tactical systems for military and security forces. The company's current portfolio of offerings includes digitization of tactical forces for real-time shared situational awareness and targeting information from any source (including drones) streamed directly to users' smart devices and weapons. Other KWESST products include countermeasures against threats such as electronic detection, lasers and drones. These systems can operate stand-alone or integrate seamlessly with OEM products and battlefield management systems, and all come integrated with TAK. The company also has a new proprietary non-lethal product line branded PARA OPSTM with application across all segments of the non-lethal market, including law enforcement. The Company is headquartered in Ottawa, Canada, with representative offices in London, UK and Abu Dhabi, UAE.
Forward-Looking Statements
This press release contains "forward-looking statements" and "forward-looking information" within the meaning of Canadian and United States securities laws (collectively, "forward-looking statements"), which may be identified by the use of words such as "plans", "is expected", "expects", "scheduled", "intends", "contemplates", "anticipates", "believes", "proposes" or variations (including negative and grammatical variations) of such words and phrases, or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such statements are based on the current expectations of KWESST's management and are based on assumptions and subject to risks and uncertainties.
Although KWESST's management believes that the assumptions underlying such statements are reasonable, they may prove to be incorrect. The forward-looking events and circumstances discussed in this press release may not occur by certain specified dates or at all and could differ materially as a result of known and unknown risk factors and uncertainties affecting KWESST, including KWESST's inability to secure contracts and subcontracts (on the timelines, size and scale expected or at all), statements of work and orders for its products in 2024 and onwards for reasons beyond its control, the renewal or extension of agreements beyond their original term, the granting of patents applied for by KWESST, inability to finance the scale up to full commercial production levels for its physical products, inability to secure key partnership agreements to facilitate the outsourcing and logistics for its Arwen and PARA OPS products, overall interest in KWESST's products being lower than anticipated or expected; general economic and stock market conditions; adverse industry events; loss of markets; future legislative and regulatory developments in Canada, the United States and elsewhere; the inability of KWESST to implement its business strategies; risks and uncertainties detailed from time to time in KWESST's filings with the Canadian Security Administrators and the United States Securities and Exchange Commission, and many other factors beyond the control of KWESST. Although KWESST has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results to differ from those anticipated, estimated or intended. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and KWESST undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Neither the TSX Venture Exchange nor its respective Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/198041
FAQ
What was KWESST's net loss in Q1 Fiscal 2024?
Why did KWESST's total revenue decrease in Q1 2024?
What caused the increase in KWESST's operating loss in Q1 2024?
How did KWESST's adjusted EBITDA loss change in Q1 Fiscal 2024 compared to the prior period?
What was KWESST's gross profit in Q1 2024 compared to the same period in 2023?
